GLP-1 Side Effects: How to Manage Nausea, Constipation, and Fatigue

Starting a GLP-1 medication like semaglutide or tirzepatide often comes with a learning curve. Nausea, constipation, and fatigue are the three most common complaints during dose escalation, and they can be discouraging enough that some patients consider stopping treatment altogether. This guide is for anyone currently on a GLP-1 protocol, or considering one, who wants practical, day-to-day strategies for managing these effects rather than just enduring them.

None of what follows replaces a conversation with a provider. It is meant to sit alongside that relationship: a reference for the small adjustments to food, hydration, movement, and timing that make the biggest day-to-day difference. We also cover the red flags that mean a symptom is no longer a manageable side effect but a reason to call your provider right away.

Individual results vary widely. Some patients move through titration with minimal disruption; others need more support at each step. Educational content. Not medical advice. A licensed-provider evaluation is the right place to discuss any side effect that concerns you or does not improve with the strategies below.

Why GLP-1 medications cause side effects

Semaglutide and tirzepatide work by mimicking gut hormones (GLP-1, and in tirzepatide's case, GIP as well) that regulate appetite and digestion. Activating these receptors slows gastric emptying, meaning food stays in the stomach longer, and signals satiety to the brain earlier than usual. That slowed digestion is the mechanism behind the medication's effectiveness for weight management, and it is also the direct cause of most side effects.

When the stomach empties more slowly, nausea and a sense of fullness are common, especially in the hours after a dose or a meal. When food and waste move more slowly through the intestines, constipation follows. When appetite drops and caloric intake falls quickly, fatigue and low energy often show up alongside it. According to the FDA Wegovy prescribing information and the FDA Zepbound prescribing information, gastrointestinal effects are the most frequently reported adverse events for both medications, and they are typically most pronounced during the first several weeks of a new dose.

Understanding the mechanism matters because it points directly at the fix: strategies that work with slowed digestion, rather than against it, tend to help the most.

Managing nausea (the #1 complaint)

Nausea is the side effect most people ask about, and it is usually most intense in the first few days after a dose increase. These strategies, drawn from how GLP-1 medications are studied in research for tolerability, tend to make the biggest difference.

• Eat smaller, more frequent meals. Large meals sit longer in a slowed stomach. Five or six small meals often cause less nausea than three large ones.
• Stop eating before you feel full. Because satiety signals arrive earlier and last longer, eating to a normal sense of fullness on a GLP-1 medication can mean you have already eaten too much.
• Avoid high-fat, greasy, or fried foods. Fat slows gastric emptying even further, compounding the effect of the medication itself. Lean proteins, plain grains, and cooked vegetables are typically better tolerated.
• Stay upright after eating. Lying down soon after a meal makes reflux and nausea more likely. Aim to stay upright for at least 30 to 60 minutes.
• Try ginger. Ginger tea, ginger chews, or ginger capsules are a commonly used, low-risk option for mild nausea.
• Sip fluids slowly and steadily. Drinking large amounts of liquid at once can worsen fullness and nausea; small, frequent sips are usually better tolerated.
• Time your dose thoughtfully. Some patients do better injecting in the evening so that peak nausea occurs overnight; others prefer mornings. There is no universal rule, so track what works for you.
• Avoid strong smells and triggers. Cooking smells, perfumes, and certain textures can trigger nausea during titration even when they were not a problem before.

If nausea is severe, persistent beyond the first couple of weeks at a given dose, or accompanied by vomiting you cannot manage, a licensed-provider evaluation can determine whether a slower titration pace, a temporary dose hold, or short-term supportive medication may be considered for eligible patients.

Managing constipation

Constipation is the second most common complaint, and it often develops gradually rather than appearing all at once. The combination of slowed gut motility and reduced food and fluid intake is usually the cause.

• Increase fiber gradually. Aim for 25 to 30 grams of fiber daily from vegetables, fruit, legumes, and whole grains. Adding fiber too quickly can worsen bloating, so build up over one to two weeks.
• Prioritize hydration. Reduced appetite often means reduced fluid intake too. Fiber without adequate water can make constipation worse, not better. A general target is half your body weight in ounces of water daily, adjusted with your provider for your individual needs.
• Consider magnesium timing. Magnesium citrate or magnesium glycinate, taken in the evening, is a commonly used over-the-counter option that draws water into the intestines and softens stool. Discuss dosing with your provider, particularly if you have kidney concerns.
• Stay physically active. Even light movement, such as a daily 20 to 30 minute walk, stimulates intestinal motility. This is one of the most consistently effective non-dietary strategies.
• Establish a consistent bathroom routine. Going at the same time each day, often after a meal when the gastrocolic reflex is strongest, can help retrain regularity.
• Don't ignore the urge. Delaying bowel movements when the urge arises tends to make constipation worse over time.

If constipation persists for more than a week despite these steps, or is accompanied by severe abdominal pain, bloating, or an inability to pass gas, contact your provider. These can be signs that dietary changes alone are not enough, or in rare cases, signs of a more serious issue that needs evaluation.

Managing fatigue and low energy

Fatigue on a GLP-1 medication is usually a downstream effect of eating less, not a direct action of the drug itself. When caloric intake drops quickly, the body has less fuel available, and that shows up as tiredness, brain fog, or low motivation, especially during the first few weeks of a new dose.

• Make sure you are eating enough. Appetite suppression can lead some patients to under-eat significantly. A licensed-provider evaluation can help establish a caloric floor appropriate for your goals so you are not running on too large a deficit.
• Prioritize protein at every meal. Protein supports muscle mass during weight loss and tends to provide more stable energy than carbohydrate-heavy meals. Many providers recommend 25 to 30 grams of protein per meal as a starting target.
• Watch your electrolytes. Reduced food intake, along with any gastrointestinal symptoms, can lower sodium, potassium, and magnesium levels. Electrolyte drinks or supplements (without added sugar) can help, particularly if you feel lightheaded or unusually tired.
• Protect your sleep. Fatigue compounds quickly when poor sleep is layered on top of reduced caloric intake. Consistent sleep and wake times make a measurable difference for most patients.
• Pace physical activity. This is not the phase to push through exhausting workouts. Lighter, consistent movement (walking, stretching, easy resistance training) tends to be better tolerated than high-intensity exercise during early titration.

Persistent, severe, or sudden-onset fatigue, especially alongside dizziness, rapid heart rate, or confusion, should prompt a call to your provider rather than a wait-and-see approach.

When to call your provider

Most GLP-1 side effects are mild to moderate and improve with the strategies above. A smaller set of symptoms are red flags that require prompt medical attention rather than home management.

• Severe or persistent abdominal pain, particularly pain that radiates to the back, can be a sign of pancreatitis. This is a rare but serious risk associated with GLP-1 medications and requires immediate evaluation.
• Pain in the upper right abdomen, especially after eating fatty food, along with nausea or fever, can indicate gallbladder disease, which has been studied in research as a potential risk with rapid weight loss and GLP-1 therapy.
• Signs of severe dehydration, including dizziness, a rapid heartbeat, very dark urine, or reduced urination, can occur when vomiting or diarrhea is significant. Severe dehydration can also affect kidney function and needs prompt attention.
• Persistent vomiting that prevents you from keeping fluids down for more than a day.
• Yellowing of the skin or eyes, which can indicate a liver or gallbladder problem.
• Any symptom that feels qualitatively different from the mild gastrointestinal discomfort you may have already experienced, especially if it is sudden, severe, or worsening.

If you experience any of these, contact your provider promptly or seek urgent care. These are exactly the situations a licensed-provider evaluation exists for, and they should never be managed with home remedies alone.

Considering a microdose or slower titration

For patients whose side effects are disruptive enough to affect daily life, a slower titration schedule or a microdose approach may be considered for eligible patients as an alternative path. Rather than increasing the dose every four weeks as a standard schedule allows, a more conservative escalation gives the digestive system additional time to adapt at each step, which can meaningfully reduce nausea, constipation, and fatigue for people who are more sensitive to the medication.

Microdosing refers to starting and maintaining doses below the standard FDA-approved starting dose. It is an off-label approach that has not been evaluated in randomized controlled trials for safety or efficacy, and it is not appropriate for every patient or every goal. It may suit patients who are highly sensitive to side effects, who want a more gradual introduction to GLP-1 therapy, or who are using the medication for a different purpose than standard weight-loss dosing.

Through Madison Meds, semaglutide and tirzepatide are available in both standard and microdose protocols, after a licensed-provider evaluation, with the medication dispensed by a US-licensed compounding pharmacy. If side effects are the main barrier to staying on treatment, this is worth raising directly with your provider. Our semaglutide microdose and tirzepatide microdose pages cover dosing structure and pricing in more detail.

Frequently asked questions

How long do GLP-1 side effects last?

Most gastrointestinal side effects such as nausea, constipation, and fatigue are most noticeable during the first 4 to 8 weeks of a dose and tend to ease as the body adjusts. Symptoms often reappear briefly after each dose increase, then settle again. Individual results vary, and some patients experience mild symptoms throughout titration while others notice very little.

How can I manage semaglutide nausea at home?

Practical strategies include eating smaller, more frequent meals, avoiding high-fat or greasy foods, stopping eating before feeling full, staying upright after meals, sipping ginger tea or electrolyte drinks, and avoiding lying down right after eating. If nausea is severe or persistent, a licensed-provider evaluation can determine whether a slower titration pace or supportive medication may be considered for eligible patients.

Why does GLP-1 medication cause constipation?

GLP-1 medications slow gastric emptying and reduce overall food intake, which can slow movement through the entire digestive tract and reduce stool bulk. Reduced fluid intake, common when appetite drops, compounds the effect. Adequate fiber, hydration, magnesium, and regular movement are the primary at-home strategies, and persistent constipation should be discussed with a provider.

Is fatigue a normal side effect of semaglutide or tirzepatide?

Yes, low energy and fatigue are commonly reported, particularly during dose escalation. Reduced caloric intake, inadequate protein, dehydration, and electrolyte shifts are the most common contributors. Prioritizing protein intake, hydration, electrolytes, and sleep typically helps. Fatigue that is severe, sudden, or accompanied by other symptoms should prompt a licensed-provider evaluation.

When should I call my provider about GLP-1 side effects?

Contact a provider promptly for severe or persistent abdominal pain (which can signal pancreatitis or gallbladder disease), persistent vomiting, signs of severe dehydration such as dizziness or very dark urine, yellowing of the skin or eyes, or any symptom that feels significantly different from typical mild gastrointestinal discomfort. These red flags are studied in research for their association with GLP-1 therapy and warrant timely evaluation rather than home management.

Does a lower dose or slower titration reduce side effects?

Slower titration and microdose approaches may be considered for eligible patients who experience significant side effects at standard escalation speed. A more gradual increase gives the digestive system more time to adapt. This is an individualized decision made through a licensed-provider evaluation, not a self-directed change to a prescribed protocol.

Compounded medications are not FDA-approved drugs. Compounded semaglutide and compounded tirzepatide are legal when prepared by a US-licensed compounding pharmacy in response to a valid prescription for an individual patient. Outcomes are individual, and the strategies described in this article do not eliminate the possibility of side effects. Educational content. Not medical advice. A licensed provider must review your medical history before starting, adjusting, or stopping either medication.